Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Decipher Labs Ltd (formerly Combat Drugs Limited), a Hyderabad-based pharmaceutical company, has called an Extra-Ordinary General Meeting on February 12, 2026 at 11:00 AM via video conferencing. The sole agenda item is the appointment of Mr. Dalavath Amar Singh (DIN: 02206249) as Director and Whole-Time Director of the company for a period of two years (till November 12, 2027), effective November 13, 2025. He will receive a remuneration of Rs. 6,00,000 per annum (Rs. 6 lakhs). Mr. Singh has prior experience in pharmaceutical plant operations, team coordination, and production. E-voting cutoff date is February 5, 2026, with remote e-voting from February 9 to February 11, 2026. The company has been in expansion mode with fluctuating financials — turnover of Rs. 87.60 lakhs in FY25 (down from Rs. 355.14 lakhs in FY24) and a net loss of Rs. 44.02 lakhs in FY25.
This is a routine governance action seeking shareholder approval for an executive director appointment already made by the board. Shareholders will vote on the appointment; no major structural change for the stock is expected. Investors may note the modest remuneration package relative to the company's small scale.